C. Savoy

12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency

J. Roemmler, C. Strasburger, D. Cook, 2013, Pituitary.

Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).

M. Bidlingmaier, P. Saenger, F. Péter, 2012, The Journal of clinical endocrinology and metabolism.

Efficacy and Safety of Valtropin™ in the Treatment of Short Stature in Girls with Turner's Syndrome

E. Orlova, P. Saenger, R. Stanhope, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.

J. Roemmler, C. Strasburger, D. Cook, 2011, The Journal of clinical endocrinology and metabolism.

Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.

S. de la Motte, M. Bidlingmaier, C. Strasburger, 2006, The Journal of clinical endocrinology and metabolism.

Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.

M. Bidlingmaier, P. Saenger, F. Péter, 2009, European journal of endocrinology.

A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Valtropin, a Biosimilar Growth Hormone, in Children with Growth Hormone Deficiency

P. Saenger, J. Kratzsch, V. Peterkova, 2007, Hormone Research in Paediatrics.

Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.

J. Roemmler, C. Strasburger, D. Cook, 2011, The Journal of clinical endocrinology and metabolism.